LadRx Corp LADX

Healthcare Biotechnology

LadRx Corp is a biopharmaceutical research and development company specializing in oncology. The Company focuses on the discovery, research and clinical development of anti-cancer drug candidates that employ technologies that target chemotherapeutic drugs to solid tumors and reduce off-target toxicities. The Company’s linker activated drug release (LADR) technology platform consists of an organic backbone that is attached to a chemo toxic agent. The LADR backbone is to first target and deliver the chemo toxic agent to the tumor environment, and then to release the chemo toxic agent within the tumor. The LADR Technology offers the opportunity for multiple pipeline drugs. The LADR development efforts are focused on two classes of ultra-high potency albumin-binding drugs. These LADR-based drugs, LADRs 7, 8, 9, and 10, combine the proprietary LADR backbone with derivatives of the auristatin and maytansinoid drug classes.

OTCQB:LADX - Post by User

LadRx Corp

Bullboard Posts

Post by fattony007on Jan 09, 2007 9:28am

108 Views

Post# 11978393

CYTR News out today

Looks like a plan to move the RNAi part of the company away from CYTR. Why? Possible strategic move to sell their tech. Good thing or bad thing??? IMO

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December